4//SEC Filing
Tendler Ely D 4
Accession 0001822359-23-000017
CIK 0001822359other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 5:32 PM ET
Size
9.5 KB
Accession
0001822359-23-000017
Insider Transaction Report
Form 4
DocGo Inc.DCGO
Tendler Ely D
DirectorGeneral Counsel, Secretary
Transactions
- Sale
Common Stock
2023-10-02$5.29/sh−10,000$52,900→ 23,088 total - Exercise/Conversion
Options to purchase Common Stock
2023-10-02−10,000→ 2,902 totalExercise: $1.59→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2023-10-02$1.59/sh+10,000$15,900→ 33,088 total
Footnotes (5)
- [F1]Exercise of options effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023 (the "10b5-1 Plan").
- [F2]Reflects 23,088 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
- [F3]Sale of shares effected pursuant to the 10b5-1 Plan.
- [F4]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.39. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F5]The options vested in three equal annual installments beginning on November 12, 2020 and expire January 1, 2030, subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by the Issuer on November 5, 2021.
Documents
Issuer
DocGo Inc.
CIK 0001822359
Entity typeother
Related Parties
1- filerCIK 0001331867
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 5:32 PM ET
- Size
- 9.5 KB